University of Rochester — Rochester, New York

Public research footprint of University of Rochester, compiled from the ClinicalTrials.gov public registry.

2,905

Registered studies

721

Active

329

Recruiting now

1,739

Completed

380

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT05564390 — MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Rochester?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.